90322-32-0

Basic information

• Product Name: 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID
• Synonyms: 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID;2-METHYL-BENZOOXAZOLE-5-CARBOXYLIC ACID;OTAVA-BB 1136981;2-Methylbenzo[d]oxazole-5-carboxylic acid;2-Methyl-5-Benzoxazolecarboxylic acid;5-Benzoxazolecarboxylic acid, 2-Methyl-
• CAS NO: 90322-32-0
• Molecular Formula: C9H7NO3
• Molecular Weight: 177.16
• Mol File: 90322-32-0.mol

Chemical Properties

• Melting Point: 186-188℃
• Appearance: /
• Density: 1.38
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID(90322-32-0)
• EPA Substance Registry System: 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID(90322-32-0)

Safety Data

• Hazardous Substances Data: 90322-32-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Formulations:
2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID is used as an active pharmaceutical ingredient for its potential therapeutic effects. Its unique structure and reactivity may contribute to the development of new drugs with specific pharmacological properties.
Used in Chemical Processes:
In the chemical industry, 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID is used as a reagent or intermediate in the synthesis of various organic compounds. Its carboxylic acid group allows for a range of chemical reactions, facilitating the creation of new molecules with diverse applications.
Used in Drug Development:
2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID is utilized as a key component in the design and synthesis of new drug candidates. Its chemical properties may offer novel mechanisms of action or improved pharmacokinetic profiles, contributing to the advancement of medicinal chemistry.
Used in Research and Development:
In academic and industrial research settings, 2-METHYL-1,3-BENZOXAZOLE-5-CARBOXYLIC ACID serves as a valuable compound for exploring new chemical reactions and understanding the underlying principles of organic chemistry. Its unique structure can provide insights into the development of innovative synthetic pathways and methodologies.

Upstream product

• 91004-38-5 3-acetamido-4-hydroxybenzoic acid 
• 108-24-7 acetic anhydride 
• 1571-72-8 3-amino-4-hydroxybenzoic acid 
• 1445-45-0 Trimethyl orthoacetate 
• 2374-03-0 4-aminosalicylic acid 
• 136663-21-3 methyl 2-methyl-1,3-benzoxazole-5-carboxylate 

Downstream Products

• 1600565-97-6 (2,4-dichloro-3-phenylquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)(2-methylbenzo[d]oxazol-5-yl)methanol 

Relevant articles and documents

GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.

Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease

The invention provides compounds of Formula I: wherein W0 is a bicyclic moiety and is These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful to treat diseases or conditions in which α7 is known to be involved.